Purpose
A concise statement of why testing or procedures are recommended and what they aim to detect, written in plain language for the patient.
Clear informed consent ensures patients understand risks and options, protects clinical decision-making, and documents that consent was voluntary and informed under applicable federal and state rules.
The patient or a legally authorized decision-maker signs to indicate understanding and agreement; copies belong in the medical chart and patient record.
The clinician who provides counseling, answers questions, documents the discussion, and witnesses consent for testing or procedures relevant to birth defect evaluation.
The patient gives informed consent personally or through an authorized surrogate when capacity is impaired; the signer affirms understanding of risks, benefits, and alternatives.
A concise statement of why testing or procedures are recommended and what they aim to detect, written in plain language for the patient.
Clear description of physical, emotional, and diagnostic limitations, including false-positive and false-negative results and procedure-specific risks.
Explanation of potential benefits such as early diagnosis, tailored prenatal care, or informed reproductive choices.
Available alternatives, including declining testing, noninvasive options, or referral to specialists, with brief comparative notes.
Statement on how results are used and protected under HIPAA and local policies, including reporting obligations if applicable.
Signature block for the patient or authorized representative with date, printed name, and clinician witness field where required.
| Field | Configuration |
|---|---|
| Authentication method | Email link or SMS code; use stronger methods for high-risk procedures. |
| Document template | Use approved clinic template with required fields and conditional sections. |
| Patient notification | Send via patient portal or secure email; log delivery and access. |
| Storage location | Save signed copy to EHR and secure document repository with audit trail. |
Platforms should meet HIPAA requirements when handling PHI; verify BAA availability, encryption in transit and at rest, and detailed audit logs before deployment.
Obtain consent before any prenatal screening or invasive diagnostic procedure.
Document the counseling session and consent in the record within 24 hours.
Label and send any samples immediately following signed consent.
Submit required public-health reports according to state rules and timelines.
Schedule follow-up or genetic counseling within a clinically appropriate timeframe.
A prenatal clinic provides the form before ultrasound-based screening
A maternal-fetal medicine practice uses an extended consent for invasive testing
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Yes | Yes | Yes | Yes |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |